Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M996Revenue $M0Net Margin (%)0Z-Score
Enterprise Value $M989EPS $0Operating Margin %0F-Score0
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)0Higher ROA y-yN
Price/Book010-y EBITDA Growth Rate %0Quick Ratio0Cash flow > EarningsN
Price/Sales05-y EBITDA Growth Rate %0Current Ratio0Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %ROA % (ttm)0Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M6.9ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with XBI

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

XBI is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


XBI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
CONDON PHILIP GPortfolio Manager 2013-11-26Buy3,000$11.751261.7 view
GABELLI MARIO JControl Person of Adviser 2013-11-26Sell35,600$21.47645.23 view
Jackson Deborah CTrustee of the Fund 2013-11-25Buy130$15.76915.23 view
FRIEDRICH ROMAN IIITrustee 2013-11-25Buy100$21.48644.88 view
Jackson Deborah CTrustee of the Fund 2013-11-25Buy130$18.19779.6 view
Jackson Deborah CTrustee of the Fund 2013-11-25Buy135$17.8798.88 view
CONDON PHILIP GPortfolio Manager 2013-11-22Buy8,500$11.81255.93 view
Dammeyer Rodney FDirector 2013-11-22Buy31,940$6.162497.4 view
BURGESS PETER STrustee of the Fund 2013-11-22Buy107$18.06785.94 view
BURGESS PETER STrustee of the Fund 2013-11-22Buy113$18.09784.47 view

Press Releases about XBI :

    Quarterly/Annual Reports about XBI:

      News about XBI:

      Articles On GuruFocus.com
      Are Earnings Important? These Days, Revenues Count for More! Mar 17 2014 

      More From Our Partners
      Is Akorn, Inc. An Easy Buy This Week? Sep 16 2014 - BENZINGA

      More From Other Websites
      Is Akorn, Inc. An Easy Buy This Week? Sep 16 2014
      Today's Thorns, Roses, and All Time Highs... Sep 15 2014
      Biotech ETFs Look to Build on Hot August Returns Sep 03 2014
      Biotechnology ETFs Show Robust Health In August Sep 02 2014
      After Recent Surge, Are Biotech ETFs Back on Track? Aug 26 2014
      Biotech Stock Boom Times Are Back Aug 26 2014
      InterMune Deal Boosts Biotech-ETFs Aug 25 2014
      The Real Divergence is Within Small-Caps Aug 21 2014
      This one stock sector can withstand all the ‘bubble’ talk Aug 21 2014
      SPDR® S&P Biotech ETF Receives Settlement Payment Aug 18 2014
      Intercept Soars, and That's Good for Fidelity Investors Aug 12 2014
      With a 2% Thud, Stocks End Worst Month Since January, Dow Negative in 2014 Jul 31 2014
      4 Biotech ETFs Beating S&P 500 Jul 29 2014
      Margin Debt Cycle: Not Dead Yet? Jul 29 2014
      Forecast Part II: Sell S&P 500 Passive Interests - This Market Is For Stock Pickers Jul 25 2014
      Dynamic And Durable Growth (Part 1) Jul 24 2014
      Earnings Beats Drive ETFs; LinkedIn Boosts Social Media ETF Jul 24 2014
      Your Best Wealth-Building Choice From Today's Top Market-Maker Price Range Forecasts Jul 21 2014
      ISI Biotech Analyst to Janet Yellen: What Bubble? Jul 18 2014
      Biotech Stock Mailbag: AcelRx, Yellen Aftermath, Nymox Jul 18 2014

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK